Latisse, which will be available by prescription starting in the first quarter of 2009, contains the active ingredient of the glaucomadrug Lumigan, which is also made by ALLERGAN.
Eyelash growth is a known side effect of Lumigan. But Lumigan and Latisse are used differently. Lumigan is an eyedrop, and Latisse gets dabbed along the lash line on the upper eyelids to promote longer, thicker, darker lashes.
Deborah Kotz wrote at the U.S. News and World Report Blog:
This drug is meant for those with a real (and often genetic) health problem called hypotrichosis, in which no hair grows on the eyelid. It may also be useful for those who've suffered permanent eyelash loss because of chemotherapy or other medical treatments.
Yes there is a condition (hyprotrichosis) wherein no hair grows on the eyelids. I just hope that Latisse is not mistaken as a solution to a beauty regimen when women just wanna have longer eyelashes for the heck of it.
0 comments:
Post a Comment